Thyroid hormone biosynthesis and release

Molecular and Cellular Endocrinology

Volumn 458, Issue , 2017, Pages 6-15

  Carvalho, Denise P ^a   Dupuy, Corinne ^b,c,d  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c CNRS   (France)

^d INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Anoctamin 1; ClC5; DUOX; NIS; Pendrin; Thyroglobulin; TPO

Indexed keywords

3,3',5' TRIIODOTHYRONINE; DEXTROTHYROXINE; HYDROGEN PEROXIDE; IODIDE; IODINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; THYROGLOBULIN; THYROID HORMONE; THYROID PEROXIDASE; AUTOANTIGEN; CHLORIDE CHANNEL; COTRANSPORTER; IODIDE PEROXIDASE; IRON BINDING PROTEIN; LIOTHYRONINE; SODIUM IODIDE SYMPORTER; THYROXINE; TPO PROTEIN, HUMAN;

ARTICLE; BASOLATERAL MEMBRANE; HORMONE STRUCTURE; HUMAN; IN VIVO STUDY; IODINATION; METABOLITE; MOLECULAR WEIGHT; NONHUMAN; OXIDATIVE COUPLING; PRIORITY JOURNAL; THYROID CELL; THYROID FOLLICLE; THYROID FOLLICULAR CELL; THYROID FUNCTION; THYROID HORMONE RELEASE; THYROID HORMONE SYNTHESIS; ANIMAL; BIOSYNTHESIS; CELL MEMBRANE; CHEMICAL STRUCTURE; CHEMISTRY; CYTOLOGY; METABOLISM; SECRETION (PROCESS);

ANIMALS; AUTOANTIGENS; CELL MEMBRANE; CHLORIDE CHANNELS; HUMANS; IODIDE PEROXIDASE; IRON-BINDING PROTEINS; MOLECULAR STRUCTURE; SYMPORTERS; THYROID EPITHELIAL CELLS; THYROID HORMONES; THYROXINE; TRIIODOTHYRONINE;

EID: 85011275779     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2017.01.038     Document Type: Article

References (136)

1. Abdalla, S.M., Bianco, A.C., Defending plasma T3 is a biological priority. Clin. Endocrinol. (Oxf) 81:5 (2014), 633–641.
2. Abramowicz, M.J., Targovnik, H.M., Varela, V., Cochaux, P., Krawiec, L., Pisarev, M.A., Propato, F.V., Juvenal, G., Chester, H.A., Vassart, G., Identification of a mutation in the coding sequence of the human thyroid peroxidase gene causing congenital goiter. J. Clin. Invest. 90 (1992), 1200–1204.
3. Afink, G., Kulik, W., Overmars, H., de Randamie, J., Veenboer, T., van Cruchten, A., Craen, M., Ris-Stalpers, C., Molecular characterization of iodotyrosine dehalogenase deficiency in patients with hypothyroidism. J. Clin. Endocrinol. Metab. 93:12 (2008), 4894–4901.
4. 2-generating activity. J. Biol. Chem. 280 (2005), 30046–30054.
5. Ameziane-El-Hassani, R., Schlumberger, M., Dupuy, C., NADPH oxidases: new actors in thyroid cancer?. Nat. Rev. Endocrinol. 12 (2016), 485–494.
6. Andrade, B.M., Araujo, R.L., Perry, R.L., Souza, E.C., Cazarin, J.M., Carvalho, D.P., Ceddia, R.B., A novel role for AMP-kinase in the regulation of the Na+/I–symporter and iodide uptake in the rat thyroid gland. Am. J. Physiol. Cell Physiol. 300:6 (2011), C1291–C1297.
7. Arriagada, A.A., Albornoz, E., Opazo, M.C., Becerra, A., Vidal, G., Fardella, C., Michea, L., Carrasco, N., Simon, F., Elorza, A.A., Bueno, S.M., Kalergis, A.M., Riedel, C.A., Excess iodide induces an acute inhibition of the sodium/iodide symporter in thyroid male rat cells by increasing reactive oxygen species. Endocrinology 156:4 (2015), 1540–1551.
8. Azouzi, N., Cailloux, J., Cazarin, J.M., Knauf, J.A., Cracchiolo, J., Al Ghuzlan, A., Hartl, D., Polak, M., Carré, A., El Mzibri, M., Filali-Maltouf, A., Al Bouzidi, A., Schlumberger, M., Fagin, J.A., Ameziane-El-Hassani, R., Dupuy, C., NADPH Oxidase NOX4 Is a Critical Mediator of BRAF(V600E)-induced Downregulation of the Sodium/Iodide Symporter in Papillary Thyroid Carcinomas. Antioxid Redox Signal Aug 22. 2016 (in press).
9. Baumann, E., Über den Jodgehalt der Schilddrüsen von Menschen und tieren. Z Physiol. Chem. 22 (1896), 1–17.
10. Berndorfer, U., Wilms, H., Herzog, V., Multimerization of thyroglobulin (TG) during extracellular storage: isolation of highly cross-linked TG from human thyroids. J. Clin. Endocrinol. Metab. 81 (1996), 1918–1926.
11. Braverman, L.E., Ingbar, S.H., Changes in thyroidal function during adaptation to large doses of iodide. J. Clin. Invest. 42 (1963), 1216–1231.
12. Cahnmann, H.J., Pommier, J., Nunez, J., Spatial requirement for coupling of iodotyrosine residues to form thyroid hormones. Proc. Natl. Acad. Sci. U. S. A. 74 (1977), 5333–5335.
13. Cardoso, L.C., Martins, D.C., Figueiredo, M.D., Rosenthal, D., Vaisman, M., Violante, A.H., Carvalho, D.P., Ca (2+)/nicotinamide adenine dinucleotide phosphate-dependent H(2)O(2) generation is inhibited by iodide in human thyroids. J. Clin. Endocrinol. Metab. 86:9 (2001), 4339–4343.
14. Carrasco, N., Thyroid hormone synthesis: thyroid iodide transport. Braverman, L.E., Cooper, D.S., (eds.) Werner & Ingbar's the Thyroid a Fundamental and Clinical Text, tenth ed., 2013, Lippincott Williams & Wilkins, Philadelphia, USA, 32–47.
15. Carre, A., Louzada, R.A., Fortunato, R.S., et al. When an intramolecular disulfide bridge governs the interaction of DUOX2 with its partner DUOXA2. Antioxid. Redox Signal 23 (2015), 724–733.
16. Carvalho, D.P., Dupuy, C., Gorin, Y., Legue, O., Pommier, J., Haye, B., Virion, A., The Ca2+-and reduced nicotinamide adenine dinucleotide phosphate-dependent hydrogen peroxide generating system is induced by thyrotropin in porcine thyroid cells. Endocrinology 137 (1996), 1007–1012.
17. Carvalho, D.P., Rego, K.G., Rosenthal, D., Thyroid peroxidase in dyshormonogenetic goiters with organification and thyroglobulin defects. Thyroid 4:4 (1994), 421–426.
18. Carvalho, D.P., Rosenthal, D., Breitenbach, M.M., Analysis of thyroglobulins 27S and 19S and their hormonal content in human thyroid glands. Braz J. Med. Biol. Res. 20:3–4 (1987), 415–418.
19. Caturegli, P., Mariotti, S., Kuppers, R.C., et al. Epitopes on thyroglobulin: a study of patients with thyroid disease. Autoimmunity 18 (1994), 41–49.
20. Cazarin, J.M., Andrade, B.M., Carvalho, D.P., AMP-activated protein kinase activation leads to lysome-mediated NA(+)/I (-)-symporter protein degradation in rat thyroid cells. Horm. Metab. Res. 46:5 (2014), 313–317.
21. Colin, I.M., Denef, J.F., Lengelé, B., Many, M.C., Gérard, A.C., Recent insights into the cell biology of thyroid angiofollicular units. Endocr. Rev. 34:2 (2013), 209–238.
22. 2+ cascades in mediating the effects of thyrotropin and iodide on hormone synthesis and secretion in human thyroid slices. J. Clin. Endocrinol. Metab. 79 (1994), 152–159.
23. 2 generation. Biochem. Biophys. Res. Commun. 154 (1988), 1287–1292.
24. Costamagna, E., García, B., Santisteban, P., The functional interaction between the paired domain transcription factor Pax8 and Smad3 is involved in transforming growth factor-beta repression of the sodium/iodide symporter gene. J. Biol. Chem. 279 (2004), 3439–3446.
25. Craps, J., Joris, V., De Jongh, B., Sonveaux, P., Horman, S., Lengelé, B., Bertrand, L., Many, M.C., Colin, I.M., Gérard, A.C., Involvement of mTOR and regulation by AMPK in early iodine deficiency-induced thyroid microvascular activation. Endocrinology 157:6 (2016), 2545–2559.
26. Craps, J., Wilvers, C., Joris, V., De Jongh, B., Vanderstraeten, J., Lobysheva, I., Balligand, J.L., Sonveaux, P., Gilon, P., Many, M.C., Gérard, A.C., Colin, I.M., Involvement of nitric oxide in iodine deficiency-induced microvascular remodeling in the thyroid gland: role of nitric oxide synthase 3 and ryanodine receptors. Endocrinology 156:2 (2015), 707–720.
27. Czarnocka, B., Ruf, J., Ferrand, M., et al. Purification of the human thyroid peroxidase and its identification as the microsomal antigen involved in autoimmune thyroid diseases. FEBS Lett. 190 (1985), 147–152.
28. Dai, G., Levy, O., Carrasco, N., Cloning and characterization of the thyroid iodide transporter. Nature, 379, 1996, 485 460.
29. De Deken, X., Wang, D., Many, M.C., et al. Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. J. Biol. Chem. 275 (2000), 23227–23233.
30. De Deken, X., Corvilain, B., Dumont, J.E., Miot, F., Roles of DUOX-mediated hydrogen peroxide in metabolism, host defense, and signaling. Antioxid. Redox Signal 20 (2014), 2776–2793.
31. De la Vieja, A., Dohan, O., Levy, O., Carrasco, N., Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology. Physiol. Rev. 80:3 (2000), 1083–1105.
32. De la Vieja, A., Ginter, C.S., Carrasco, N., Molecular analysis of a congenital iodide transport defect: G543E impairs maturation and trafficking of the Na+/I- symporter. Mol. Endocrinol. 19:11 (2005), 2847–2858.
33. De la Vieja, A., Reed, M.D., Ginter, C.S., Carrasco, N., Amino acid residues in transmembrane segment IX of the Na+/I- symporter play a role in its Na+ dependence and are critical for transport activity. J. Biol. Chem. 282:35 (2007), 25290–25298.
34. de Souza, E.C., Dias, G.R., Cardoso, R.C., Lima, L.P., Fortunato, R.S., Visser, T.J., Vaisman, M., Ferreira, A.C., Carvalho, D.P., MCT8 is downregulated by short time iodine overload in the thyroid gland of rats. Horm. Metab. Res. 47:12 (2015), 910–915.
35. de Souza, E.C., Padrón, A.S., Braga, W.M., de Andrade, B.M., Vaisman, M., Nasciutti, L.E., Ferreira, A.C., de Carvalho, D.P., MTOR downregulates iodide uptake in thyrocytes. J. Endocrinol. 206:1 (2010), 113–120.
36. de Vijlder, J.J., den Hartog, M.T., Anionic iodotyrosine residues are required for iodothyronine synthesis. Eur. J. Endocrinol. 138 (1998), 227–231.
37. Deme, D., Virion, A., Hammou, N.A., Pommier, J., NADPH-dependent generation of H2O2 in a thyroid particulate fraction requires Ca2+. FEBS Lett. 186 (1985), 107–110.
38. Demeester-Mirkine, N., Van Sande, J., Corvilain, J., Dumont, J.E., Benign thyroid nodule with normal iodide trap and defective organification. J. Clin. Endocrinol. Metab. 41 (1975), 1169–1171.
39. Di Cosmo, C., Liao, X.H., Dumitrescu, A.M., Philp, N.J., Weiss, R.E., Refetoff, S., Mice deficient in MCT8 reveal a mechanism regulating thyroid hormone secretion. J. Clin. Invest. 120:9 (2010), 3377–3388.
40. Di Jeso, B., Arvan, P., Thyroglobulin from molecular and cellular biology to clinical endocrinology. Endocr. Rev. 37 (2016), 2–36.
41. Dohan, O., Baloch, Z., Banrevi, Z., Livolsi, V., Carrasco, N., Rapid communication: predominant intracellular overexpression of the Na(+)/I (-) symporter (NIS) in a large sampling of thyroid cancer cases. J. Clin. Endocrinol. Metabolism 86 (2001), 2697–2700.
42. Dohan, O., Vieja, A., Paroder, V., Riedel, C., Artani, M., Reed, M., Ginter, C.S., Carrasco, N., The sodium/iodide symporter (NIS): characterization, regulation, and medical significance. Endocr. Rev. 24 (2003), 48–77.
43. Donkó, Á., Morand, S., Korzeniowska, A., Boudreau, H.E., Zana, M., Hunyady, L., Geiszt, M., Leto, T.L., Hypothyroidism-associated missense mutation impairs NADPH oxidase activity and intracellular trafficking of Duox2. Free Radic. Biol. Med. 73 (2014), 190–200.
44. Dunn, A.D., Crutchfield, H.E., Dunn, J.T., Proteolytic processing of thyroglobulin by extracts of thyroid lysosomes. Endocrinology 128 (1991), 3073–3080.
45. Dunn, A.D., Crutchfield, H.E., Dunn, J.T., Thyroglobulin processing by thyroidal proteases. Major sites of cleavage by cathepsins B, D, and L. J. Biol. Chem. 266 (1991), 20198–20204.
46. Dunn, J.T., Dunn, A.D., The importance of thyroglobulin structure for thyroid hormone biosynthesis. Biochimie 81:5 (1999), 505–509.
47. Dunn, J.T., Dunn, A.D., Update on intrathyroidal iodine metabolism. Thyroid 11 (2001), 407–414.
48. Dupuy, C., Ohayon, R., Valent, A., et al. Purification of a novel flavoprotein involved in the thyroid NADPH oxidase. Cloning of the porcine and human cDNAs. J. Biol. Chem. 274 (1999), 37265–37269.
49. Eng, P.H.K., Cardona, G.R., Fang, S.L., Previti, M., Alex, S., Carrasco, N., Chin, W.W., Braverman, L.E., Escape from the acute Wolff Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein. Endocrinology 140 (1999), 3404–3410.
50. Ericson, L.E., Exocytosis and endocytosis in the thyroid follicle cell. Mol. Cell Endocrinol. 22 (1981), 1–24.
51. - symporter – mechanism, stoichiometry, and specificity. J. Biol. Chem. 272 (1997), 27230–27238.
52. 2 generated at the apical surface of thyroid cells in autocatalytic covalent heme binding. J. Biol. Chem. 274 (1999), 10533–10538.
53. Fernando, R., Lu, Y., Atkins, S.J., Mester, T., Branham, K., Smith, T.J., Expression of thyrotropin receptor, thyroglobulin, sodium-iodide symporter, and thyroperoxidase by fibrocytes depends on AIRE. J. Clin. Endocrinol. Metab. 99 (2014), E1236–E1244.
54. Ferrand, M., Le Fourn, V., Franc, J.L., Increasing diversity of human thyroperoxidase generated by alternative splicing. Characterized by molecular cloning of new transcripts with single- and multispliced mRNAs. J. Biol. Chem. 278 (2003), 3793–3800.
55. Ferreira, A.C., Lima, L.P., Araujo, R.L., Muller, G., Rocha, R.P., Rosenthal, D., Carvalho, D.P., Rapid regulation of thyroid sodium-iodide symporter activity by thyrotrophin and iodine. J. Endocrinol. 184:1 (2005), 69–76.
56. Figueiredo, M.D., Cardoso, L.C., Ferreira, A.C., Campos, D.V., da Cruz Domingos, M., Corbo, R., Nasciutti, L.E., Vaisman, M., Carvalho, D.P., Goiter and hypothyroidism in two siblings due to impaired Ca(+2)/NAD(P)H-dependent H(2)O(2)-generating activity. J. Clin. Endocrinol. Metab. 86:10 (2001), 4843–4848.
57. Fortunato, R.S., Lima de Souza, E.C., Ameziane-El-Hassani, R., et al. Functional consequences of dual oxidase-thyroperoxidase interaction at the plasma membrane. J. Clin. Endocrinol. Metab. 95 (2010), 5403–5411.
58. Friedrichs, B., Tepel, C., Reinheckel, T., Deussing, J., von Figura, K., Herzog, V., Peters, C., Saftig, P., Brix, K., Thyroid functions of mouse cathepsins B, K, and L. J. Clin. Invest. 111 (2003), 1733–1745.
59. Friesema, E.C., Grueters, A., Biebermann, H., Krude, H., von Moers, A., Reeser, M., Barrett, T.G., Mancilla, E.E., Svensson, J., Kester, M.H., Kuiper, G.G., Balkassmi, S., Uitterlinden, A.G., Koehrle, J., Rodien, P., Halestrap, A.P., Visser, T.J., Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation. Lancet 364 (2004), 1435–1437.
60. Galrão, A.L., Camargo, R.Y., Friguglietti, C.U., Moraes, L., Cerutti, J.M., Serrano-Nascimento, C., Suzuki, M.F., Medeiros-Neto, G., Rubio, I.G., Hypermethylation of a New Distal Sodium/Iodide Symporter (NIS) enhancer (NDE) is associated with reduced NIS expression in thyroid tumors. J. Clin. Endocrinol. Metab. 99:6 (2014), E944–E952.
61. Galrão, A.L., Sodré, A.K., Camargo, R.Y., Friguglietti, C.U., Kulcsar, M.A., Lima, E.U., Medeiros-Neto, G., Rubio, I.G., Methylation levels of sodium-iodide symporter (NIS) promoter in benign and malignant thyroid tumors with reduced NIS expression. Endocrine 43:1 (2013), 225–229.
62. Gavaret, J.M., Cahnmann, H.J., Nunez, J., Thyroid hormone synthesis in thyroglobulin. The mechanism of the coupling reaction. J. Biol. Chem. 256 (1981), 9167–9173.
63. Gerard, C.M., Lefort, A., Libert, F., et al. Transcriptional regulation of the thyroperoxydase gene by thyrotropin and forskolin. Mol. Cell Endocrinol. 60 (1988), 239–242.
64. Gereben, B., Salvatore, D., Harney, J.W., Tu, H.M., Larsen, P.R., The human, but not rat, dio2 gene is stimulated by thyroid transcription factor-1 (TTF-1). Mol. Endocrino 15:1 (2001), 112–124.
65. Gillam, M.P., Sidhaye, A.R., Lee, E.J., Rutishauser, J., Stephan, C.W., Kopp, P., Functional characterization of pendrin in a polarized cell system. Evidence for pendrin-mediated apical iodide efflux. J. Biol. Chem. 26:13 (2004), 13004–13010 279.
66. Gnidehou, S., Caillou, B., Talbot, M., et al. Iodotyrosine dehalogenase 1 (DEHAL1) is a transmembrane protein involved in the recycling of iodide close to the thyroglobulin iodination site. FASEB J. 18 (2004), 1574–1576.
67. Godlewska, M., Góra, M., Buckle, A.M., Porebski, B.T., Kemp, E.H., Sutton, B.J., Czarnocka, B., Banga, J.P., A redundant role of human thyroid peroxidase propeptide for cellular, enzymatic, and immunological activity. Thyroid 24 (2014), 371–382.
68. Grasberger, H., Defects of thyroidal hydrogen peroxide generation in congenital hypothyroidism. Mol. Cell Endocrinol. 322 (2010), 99–106.
69. Grasberger, H., De Deken, X., Mayo, O.B., Raad, H., Weiss, M., Liao, X.H., Refetoff, S., Mice deficient in dual oxidase maturation factors are severely hypothyroid. Mol. Endocrinol. 26:3 (2012), 481–492.
70. Grasberger, H., Refetoff, S., Identification of the maturation factor for dual oxidase. Evolution of an eukaryotic operon equivalent. J. Biol. Chem. 281 (2006), 18269–18272.
71. Grasberger, H., Ringkananont, U., Lefrancois, P., et al. Thyroid transcription factor 1 rescues PAX8/p300 synergism impaired by a natural PAX8 paired domain mutation with dominant negative activity. Mol. Endocrinol. 19 (2005), 1779–1791.
72. Grollman, E.F., Smolar, A., Ommaya, A., Tombaccini, D., Santisteban, P., Iodine suppression of iodide uptake in FRTL-5 thyroid cells. Endocrinology 118 (1986), 2477–2482.
73. Herzog, V., Berndorfer, U., Saber, Y., Isolation of insoluble secretory product from bovine thyroid: extracellular storage of thyroglobulin in covalently cross-linked form. J. Cell Biol. 118 (1992), 1071–1083.
74. Hishinuma, A., Takamatsu, J., Ohyama, Y., et al. Two novel cysteine substitutions (C1263R and C1995S) of thyroglobulin cause a defect in intracellular transport of thyroglobulin in patients with congenital goiter and the variant type of adenomatous goiter. J. Clin. Endocrinol. Metab. 84 (1999), 1438–1444.
75. Hoste, C., Rigutto, S., Van, V.G., et al. Compound heterozygosity for a novel hemizygous missense mutation and a partial deletion affecting the catalytic core of the H(2)O(2)-generating enzyme DUOX2 associated with transient congenital hypothyroidism. Hum. Mutat. 31 (2010), E1304–E1319.
76. Iosco, C., Cosentino, C., Sirna, L., Romano, R., Cursano, S., Mongia, A., Pompeo, G., di Bernardo, J., Ceccarelli, C., Tallini, G., Rhoden, K.J., Anoctamin 1 is apically expressed on thyroid follicular cells and contributes to ATP- and calcium-activated iodide efflux. Cell Physiol. Biochem. 34:3 (2014), 966–980.
77. Jordans, S., Jenko-Kokalj, S., Kühl, N.M., Tedelind, S., Sendt, W., Brömme, D., Turk, D., Brix, K., Monitoring compartment-specific substrate cleavage by cathepsins B, K, L, and S at physiological pH and redox conditions. BMC Biochem. 10 (2009), 1–15.
78. —transporting cultured thyroid cells. Proc. Natl. Acad. Sci. U. S. A. 91 (1994), 3789–3793.
79. Kero, J., Ahmed, K., Wettschureck, N., Tunaru, S., Wintermantel, T., Greiner, E., Schütz, G., Offermanns, S., Thyrocyte-specific Gq/G11 deficiency impairs thyroid function and prevents goiter development. J. Clin. Invest. 117 (2007), 2399–2407.
80. Kimura, S., Kotani, T., McBride, O.W., et al. Human thyroid peroxidase: complete cDNA and protein sequence, chromosome mapping, and identification of two alternately spliced mRNAs. Proc. Natl. Acad. Sci. U. S. A. 84 (1987), 5555–5559.
81. Kohn, L.D., Suzuki, K., Nakazato, M., Royaux, I., Green, E.D., Effects of thyroglobulin and pendrin on iodide flux through the thyrocyte. Trends Endocrinol. Metab. 12 (2001), 10–16.
82. Le Fourn, V., Ferrand, M., Franc, J.L., Differential expression of thyroperoxidase mRNA splice variants in human thyroid tumors. Biochim. Biophys. Acta 1689 (2004), 134–141.
83. Le Fourn, V., Ferrand, M., Franc, J.L., Endoproteolytic cleavage of human thyroperoxidase: role of the propeptide in the protein folding process. J. Biol. Chem. 280 (2005), 4568–4577.
84. Leoni, S.G., Kimura, E.T., Santisteban, P., De la Vieja, A., Regulation of thyroid oxidative state by thioredoxin reductase has a crucial role in thyroid responses to iodide excess. Mol. Endocrinol. 25:11 (2011), 1924–1935.
85. Leoni, S.G., Sastre-Perona, A., De la Vieja, A., Santisteban, P., Selenium increases thyroid-stimulating hormone-induced sodium/iodide symporter expression through thioredoxin/apurinic/apyrimidinic endonuclease 1-dependent regulation of paired box 8 binding activity. Antioxid. Redox Signal 24 (2016), 855–866.
86. Levy, O., Dai, G., Riedel, C., Ginter, C.S., Paul, E.M., Lebowitz, A.N., Carrasco, N., Characterization of the thyroid Na+/I– symporter with an anti-COOH terminus antibody. Proc. Natl. Acad. Sci. U. S. A. 94 (1997), 5568–5573.
87. Levy, O., De la Vieja, A., Ginter, C.S., Riedel, C., Dai, G., Carrasco, N., N-linked glycosylation of the thyroid Na+/I– symporter (NIS). Implications for its secondary structure model. J. Biol. Chem. 273 (1998), 22657–22663.
88. Lisi, S., Pinchera, A., McCluskey, R.T., Willnow, T.E., Refetoff, S., Marcocci, C., Vitti, P., Menconi, F., Grasso, L., Luchetti, F., Collins, A.B., Marino, M., Preferential megalin-mediated transcytosis of low-hormonogenic thyroglobulin: a control mechanism for thyroid hormone release. Proc. Natl. Acad. Sci. U. S. A. 100 (2003), 14858–14863.
89. López-Espíndola, D., Morales-Bastos, C., Grijota-Martínez, C., Liao, X.H., Lev, D., Sugo, E., Verge, C.F., Refetoff, S., Bernal, J., Guadaño-Ferraz, A., Mutations of the thyroid hormone transporter MCT8 cause prenatal brain damage and persistent hypomyelination. J. Clin. Endocrinol. Metab. 99 (2014), E2799–E2804.
90. Luo, Y., Akama, T., Okayama, A., Yoshihara, A., Sue, M., Oda, K., Hayashi, M., Ishido, Y., Hirano, H., Hiroi, N., Katoh, R., Suzuki, K., A novel role for flotillin-containing lipid rafts in negative-feedback regulation of thyroid-specific gene expression by thyroglobulin. Thyroid 26:11 (2016 Nov), 1630–1639.
91. Malthiery, Y., Lissitzky, S., Primary structure of human thyroglobulin deduced from the sequence of its 8 448-base complementary DNA. Eur. J. Biochem. 165 (1987), 491–498.
92. Maruo, Y., Takahashi, H., Soeda, I., et al. Transient congenital hypothyroidism caused by biallelic mutations of the dual oxidase 2 gene in Japanese patients detected by a neonatal screening program. J. Clin. Endocrinol. Metab. 93 (2008), 4261–4267.
93. Mendive, F.M., Rivolta, C.M., Moya, C.M., et al. Genomic organization of the human thyroglobulin gene: the complete intron-exon structure. Eur. J. Endocrinol. 145 (2001), 485–496.
94. Miccadei, S., De Leo, R., Zammarchi, E., et al. The synergistic activity of thyroid transcription factor 1 and Pax8 relies on the promoter/enhancer interplay. Mol. Endocrinol. 16 (2002), 837–846.
95. Morand, S., Chaaraoui, M., Kaniewski, J., et al. Effect of iodide on nicotinamide adenine dinucleotide phosphate oxidase activity and Duox2 protein expression in isolated porcine thyroid follicles. Endocrinology 144 (2003), 1241–1248.
96. Moreno, J.C., Bikker, H., Kempers, M.J., et al. Inactivating mutations in the gene for thyroid oxidase 2 (THOX2) and congenital hypothyroidism. N. Engl. J. Med. 347 (2002), 95–102.
97. Moreno, J.C., Klootwijk, W., van Toor, H., Pinto, G., D'Alessandro, M., Lèger, A., Goudie, D., Polak, M., Grüters, A., Visser, T.J., Mutations in the iodotyrosine deiodinase gene and hypothyroidism. N. Engl. J. Med. 358 (2008), 1811–1818.
98. Morgan, S.J., Neumann, S., Marcus-Samuels, B., Gershengorn, M.C., Thyrotropin and insulin-like growth factor 1 receptor crosstalk upregulates sodium-iodide symporter expression in primary cultures of human thyrocytes. Thyroid 26 (2016), 1794–1803.
99. Nakazato, M., Chung, H.K., Ulianich, L., Grassadonia, A., Suzuki, K., Kohn, L.D., Thyroglobulin repression of thyroid transcription factor 1 (TTF-1) gene expression is mediated by decreased DNA binding of nuclear factor I proteins which control constitutive TTF-1 expression. Mol. Cell Biol. 20 (2000), 8499–8512.
100. Noguchi, Y., Harii, N., Giuliani, C., Tatsuno, I., Suzuki, K., Kohn, L.D., Thyroglobulin (Tg) induces thyroid cell growth in a concentration-specific manner by a mechanism other than thyrotropin/cAMP stimulation. Biochem. Biophys. Res. Commun. 391 (2010), 890–894.
101. Ohno, M., Zannini, M., Levy, O., Carrasco, N., di Lauro, R., The paired-domain transcription factor Pax8 binds to the upstream enhancer of the rat sodium/iodide symporter gene and participates in both thyroid-specific and cyclic-AMP-dependent transcription. Mol. Cell Biol. 19:3 (1999), 2051–2060.
102. Padron, A.S., Neto, R.A., Pantaleão, T.U., de Souza dos Santos, M.C., Araujo, R.L., de Andrade, B.M., da Silva Leandro, M., de Castro, J.P., Ferreira, A.C., de Carvalho, D.P., Administration of 3,5-diiodothyronine (3,5-T2) causes central hypothyroidism and stimulates thyroid-sensitive tissues. J. Endocrinol. 221:3 (2014), 415–427.
103. Price, D.J., Sherwin, J.R., Autoregulation of iodide transport in the rabbit: absence of autoregulation in fetal tissue and comparison of maternal and fetal thyroid iodination products. Endocrinology 119 (1986), 2547–2552.
104. + channel is required for adequate thyroid I⁻ uptake. FASEB J. 26 (2012), 3252–3259.
105. Riedel, C., Levy, O., Carrasco, N., Post-transcriptional regulation of the sodium/iodide symporter by thyrotropin. J. Biol. Chem. 276:24 (2001 Jun 15), 21458–21463.
106. Riesco-Eizaguirre, G., Rodríguez, I., De la Vieja, A., Costamagna, E., Carrasco, N., Nistal, M., Santisteban, P., The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer. Cancer Res. 69 (2009), 8317–8325.
107. Rigutto, S., Hoste, C., Grasberger, H., et al. Activation of dual oxidases Duox1 and Duox2: differential regulation mediated by camp-dependent protein kinase and protein kinase C-dependent phosphorylation. J. Biol. Chem. 284 (2009), 6725–6734.
108. Ris-Stalpers, C., Bikker, H., Genetics and phenomics of hypothyroidism and goiter due to TPO mutations. Mol. Cell Endocrinol. 30:1–2 (2010), 38–43 322.
109. Roepke, T.K., King, E.C., Reyna-Neyra, A., Paroder, M., Purtell, K., Koba, W., Fine, E., Lerner, D.J., Carrasco, N., Abbott, G.W., Kcne2 deletion uncovers its crucial role in thyroid hormone biosynthesis. Nat. Med. 15:10 (2009), 1186–1194.
110. Royaux, I.E., Suzuki, K., Mori, A., Katoh, R., Everett, L.A., Kohn, L.D., Green, E.D., Pendrin, the protein encoded by the Pendred syndrome gene (PDS), is an apical porter of iodide in the thyroid and is regulated by thyroglobulin in FRTL-5 cells. Endocrinology 141 (2000), 839–845.
111. Schanze, N., Jacobi, S.F., Rijntjes, E., Mergler, S., Del Olmo, M., Hoefig, C.S., Khajavi, N., Lehmphul, I., Biebermann, H., Mittag, J., Köhrle, J., 3-Iodothyronamine decreases expression of genes involved in iodide metabolism in mouse thyroids and inhibits iodide uptake in PCCL3 thyrocytes. Thyroid 27 (2017), 11–22, 10.1089/thy.2016.0182.
112. Schumm-Draeger, P.M., Sodium/iodide symporter (NIS) and cytokines. Exp. Clin. Endocrinol. Diabetes 109 (2001), 32–34.
113. Schwartz, C.E., Stevenson, R.E., The MCT8 thyroid hormone transporter and Allan-Herndon-Dudley syndrome. Best. Pract. Res. Clin. Endocrinol. Metab. 21 (2007), 307–321.
114. Scott, D.A., Wang, R., Kreman, T.M., Sheffield, V.C., Karniski, L.P., The Pendred syndrome gene encodes a chloride-iodide transport protein. Nat. Genet. 21:4 (1999), 440–443.
115. Senou, M., Costa, M.J., Massart, C., Thimmesch, M., Khalifa, C., Poncin, S., Boucquey, M., Gérard, A.C., Audinot, J.N., Dessy, C., Ruf, J., Feron, O., Devuyst, O., Guiot, Y., Dumont, J.E., Van Sande, J., Many, M.C., Role of caveolin-1 in thyroid phenotype, cell homeostasis, and hormone synthesis: in vivo study of caveolin-1 knockout mice. Am. J. Physiol. Endocrinol. Metabm 297 (2009), E438–E451.
116. Serrano-Nascimento, C., da Silva Teixeira, S., Nicola, J.P., Nachbar, R.T., Masini-Repiso, A.M., Nunes, M.T., The acute inhibitory effect of iodide excess on sodium/iodide symporter expression and activity involves the PI3K/Akt signaling pathway. Endocrinology 155:3 (2014), 1145–1156.
117. Smanik, P.A., Liu, Q., Furminger, T.L., Ryu, K., Xing, S., Mazzaferri, E.L., Jhiang, S.M., Cloning of the human sodium iodide symporter. Biochem. Biophysical Res. Commun. 226 (1996), 339–345.
118. Smanik, P.A., Ryu, K.Y., Theil, K.S., Mazzaferri, E.L., Jhiang, S.M., Expression, exon-intron organization, and chromosome mapping of the human sodium iodide symporter. Endocrinology 138:8 (1997), 3555–3558.
119. Smith, T.J., TSH-receptor-expressing fibrocytes and thyroid-associated ophthalmopathy. Nat. Rev. Endocrinol. 11 (2015), 171–181.
120. Song, Y., Ruf, J., Lothaire, P., et al. Association of duoxes with thyroid peroxidase and its regulation in thyrocytes. J. Clin. Endocrinol. Metab. 95 (2010), 375–382.
121. Suzuki, K., Kohn, L.D., Differential regulation of apical and basal iodide transporters in the thyroid by thyroglobulin. J. Endocrinol. 189 (2006), 247–255.
122. Suzuki, K., Lavaroni, S., Mori, A., Ohta, M., Saito, J., Pietrarelli, M., Singer, D.S., Kimura, S., Katoh, R., Kawaoi, A., Kohn, L.D., Autoregulation of thyroid-specific gene transcription by thyroglobulin. Proc. Natl. Acad. Sci. U. S. A. 95 (1998), 8251–8256.
123. Suzuki, K., Nakazato, M., Ulianich, L., Mori-Aoki, A., Moriyama, E., Chung, H.K., Pietrarelli, M., Grassadonia, A., Matoba, H., Kohn, L.D., Thyroglobulin autoregulation of thyroid-specific gene expression and follicular function. Rev. Endocr. Metab. Disord. 1 (2000), 217–224.
124. Targovnik, H.M., Thyroid hormone synthesis: thyroid iodide transport. Braverman, L.E., Cooper, D.S., (eds.) Werner & Ingbar's the Thyroid a Fundamental and Clinical Text, tenth ed., 2013, Lippincott Williams & Wilkins, Philadelphia, USA, 74–92.
125. Taurog, A., Molecular evolution of thyroid peroxidase. Biochimie 81 (1999), 557–562.
126. Tonacchera, M., Viacava, P., Agretti, P., de Marco, G., Perri, A., di Cosmo, C., de Servi, M., Miccoli, P., Lippi, F., Naccarato, A.G., Pinchera, A., Chiovato, L., Vitti, P., Benign nonfunctioning thyroid adenomas are characterized by a defective targeting to cell membrane or a reduced expression of the sodium iodide symporter protein. J. Clin. Endocrinol. Metabolism 87 (2002), 352–357.
127. Twyffels, L., Strickaert, A., Virreira, M., Massart, C., Van Sande, J., Wauquier, C., Beauwens, R., Dumont, J.E., Galietta, L.J., Boom, A., Kruys, V., Anoctamin-1/TMEM16A is the major apical iodide channel of the thyrocyte. Am. J. Physiol. Cell Physiol. 15:12 (2014), C1102–C1112 307.
128. Ulianich, L., Suzuki, K., Mori, A., Nakazato, M., Pietrarelli, M., Goldsmith, P., Pacifico, F., Consiglio, E., Formisano, S., Kohn, L.D., Follicular thyroglobulin (TG) suppression of thyroid-restricted genes involves the apical membrane asialoglycoprotein receptor and TG phosphorylation. J. Biol. Chem. 274 (1999), 25099–25107.
129. Uyttersprot, N., Pelgrims, N., Carrasco, N., Gervy, C., Maenhaut, C., Dumont, J.E., Miot, F., Moderate doses of iodide in vivo inhibit cell proliferation and the expression of thyroperoxidase and Na+/I- symporter mRNAs in dog thyroid. Mol. Cell Endocrinol. 8:2 (1997), 195–203 131.
130. van den Hove, M.F., Croizet-Berger, K., Jouret, F., Guggino, S.E., Guggino, W.B., Devuyst, O., Courtoy, P.J., The loss of the chloride channel, ClC-5, delays apical iodide efflux and induces a euthyroid goiter in the mouse thyroid gland. Endocrinology 147:3 (2006), 1287–1296.
131. Vanderstraeten, J., Derradji, H., Craps, J., Sonveaux, P., Colin, I.M., Many, M.C., Gérard, A.C., Iodine deficiency induces a VEGF-dependent microvascular response in salivary glands and in the stomach. Histol. Histopathol. 31:8 (2016), 897–909.
132. Virion, A., Michot, J.L., Deme, D., Kaniewski, J., Pommier, J., NADPH-dependent H2O2 generation and peroxidase activity in thyroid particular fraction. Mol. Cell Endocrinol. 36 (1984), 95–105.
133. Virion, A., Iodation de la thyroglobuline et formation des résidus hormonaux. Inhibition par les antithyroïdiens de synthèse. Leclère, J., Orgiazzi, J., Rousset, B., et al. (eds.) La Thyroïde, 2e éd, 2001, Elsevier, Paris, 40–47.
134. Wolff, J., Chaikoff, I.L., Plasma inorganic iodide as a homeostatic regulator of thyroid function. J. Biol. Chem. 174 (1948), 555–564.
135. Zaballos, M.A., Garcia, B., Santisteban, P., G betagamma dimers released in response to thyrotropin activate phosphoinositide 3-kinase and regulate gene expression in thyroid cells. Mol. Endocrinol. 22:5 (2008), 1183–1199.
136. Zamproni, I., Grasberger, H., Cortinovis, F., Vigone, M.C., Chiumello, G., Mora, S., Onigata, K., Fugazzola, L., Refetoff, S., Persani, L., Weber, G., Biallelic inactivation of the dual oxidase maturation factor 2 (DUOXA2) gene as a novel cause of congenital hypothyroidism. J. Clin. Endocrinol. Metab. 93 (2008), 605–610.